166 related articles for article (PubMed ID: 23056920)
1. Superior Silencing by 2',4'-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2',4'-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors.
Yamamoto T; Yasuhara H; Wada F; Harada-Shiba M; Imanishi T; Obika S
J Nucleic Acids; 2012; 2012():707323. PubMed ID: 23056920
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice.
Yamamoto T; Harada-Shiba M; Nakatani M; Wada S; Yasuhara H; Narukawa K; Sasaki K; Shibata MA; Torigoe H; Yamaoka T; Imanishi T; Obika S
Mol Ther Nucleic Acids; 2012 May; 1(5):e22. PubMed ID: 23344002
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and properties of 2',4'-BNA(NC): a bridged nucleic acid analogue.
Rahman SM; Seki S; Obika S; Yoshikawa H; Miyashita K; Imanishi T
J Am Chem Soc; 2008 Apr; 130(14):4886-96. PubMed ID: 18341342
[TBL] [Abstract][Full Text] [Related]
4. Target gene knockdown by 2',4'-BNA/LNA antisense oligonucleotides in zebrafish.
Itoh M; Nakaura M; Imanishi T; Obika S
Nucleic Acid Ther; 2014 Jun; 24(3):186-91. PubMed ID: 24460393
[TBL] [Abstract][Full Text] [Related]
5. Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes.
Jackson A; Jani S; Sala CD; Soler-Bistué AJ; Zorreguieta A; Tolmasky ME
Biol Methods Protoc; 2016 Mar; 1(1):. PubMed ID: 27857983
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bcl-xL expression by antisense oligonucleotides containing various bridged nucleic acids (BNAs).
Roongjang S; Takahashi K; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2007; (51):113-4. PubMed ID: 18029612
[TBL] [Abstract][Full Text] [Related]
7. Optimization of 2',4'-BNA/LNA-Based Oligonucleotides for Splicing Modulation In Vitro.
Shimo T; Obika S
Methods Mol Biol; 2018; 1828():395-411. PubMed ID: 30171556
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models.
Prakash TP; Siwkowski A; Allerson CR; Migawa MT; Lee S; Gaus HJ; Black C; Seth PP; Swayze EE; Bhat B
J Med Chem; 2010 Feb; 53(4):1636-50. PubMed ID: 20108935
[TBL] [Abstract][Full Text] [Related]
10. Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.
Straarup EM; Fisker N; Hedtjärn M; Lindholm MW; Rosenbohm C; Aarup V; Hansen HF; Ørum H; Hansen JB; Koch T
Nucleic Acids Res; 2010 Nov; 38(20):7100-11. PubMed ID: 20615897
[TBL] [Abstract][Full Text] [Related]
11. Free-radical ring closure to conformationally locked α-L-carba-LNAs and synthesis of their oligos: nuclease stability, target RNA specificity, and elicitation of RNase H.
Li Q; Yuan F; Zhou C; Plashkevych O; Chattopadhyaya J
J Org Chem; 2010 Sep; 75(18):6122-40. PubMed ID: 20738147
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and properties of 2'-O,4'-C-spirocyclopropylene bridged nucleic acid (scpBNA), an analogue of 2',4'-BNA/LNA bearing a cyclopropane ring.
Yamaguchi T; Horiba M; Obika S
Chem Commun (Camb); 2015 Jun; 51(47):9737-40. PubMed ID: 25985928
[TBL] [Abstract][Full Text] [Related]
13. Bridged Nucleic Acids Reloaded.
Soler-Bistué A; Zorreguieta A; Tolmasky ME
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234313
[TBL] [Abstract][Full Text] [Related]
14. BNA
Manning KS; Rao AN; Castro M; Cooper TA
ACS Chem Biol; 2017 Oct; 12(10):2503-2509. PubMed ID: 28853853
[TBL] [Abstract][Full Text] [Related]
15. Effective syntheses of 2',4'-BNA
Fujisaka A; Hari Y; Takuma H; Rahman SMA; Yoshikawa H; Pang J; Imanishi T; Obika S
Bioorg Med Chem; 2019 Apr; 27(8):1728-1741. PubMed ID: 30862430
[TBL] [Abstract][Full Text] [Related]
16. High-affinity RNA mimicking binding of 2',4'-BNANC towards complementary strands: a comparative study with 2',4'-BNA/LNA.
Rahman SM; Seki S; Utsuki K; Obika S; Miyashita K; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2006; (50):195-6. PubMed ID: 17150884
[TBL] [Abstract][Full Text] [Related]
17. Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma.
Yamamoto T; Obika S; Nakatani M; Yasuhara H; Wada F; Shibata E; Shibata MA; Harada-Shiba M
Eur J Pharmacol; 2014 Jan; 723():353-9. PubMed ID: 24269597
[TBL] [Abstract][Full Text] [Related]
18. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
19. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug.
Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem Lett; 2002 Jan; 12(1):73-6. PubMed ID: 11738576
[TBL] [Abstract][Full Text] [Related]
20. [Down-regulation of a gene-expression by an antisense BNA oligonucleotide].
Imanishi T; Obika S
Nihon Yakurigaku Zasshi; 2002 Aug; 120(2):85-90. PubMed ID: 12187626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
